CDMO Blog

How Can a Closed CAR-T Manufacturing Process De-Risk Your Process, Reduce Costs and Improve Efficiency?

Instrument enabling Car-T process development

In a previous post we introduced chimeric antigen receptor T-cell (CAR-T) therapy - a new form of cancer therapy based on genetically reprogramming the body’s immune system that has been described as a “breakthrough” and “revolutionary” by the medical and scientific communities.

Read More
Posted: Oct 24, 2019 3:22:49 PM

How Do CAR-T Cells Work to Engineer a Patients Immune System to Fight Cancer?

Scientist working with cellsConventional cancer treatments (e.g. surgery, chemotherapy/radiation) do not specifically target cancer cells and, as a result, can cause extensive off-target damage, and complications for patients.

Read More
Posted: Sep 1, 2019 12:58:57 PM